Skip to content

To Evaluate The Therapeutic effect Of Unani Formulation(Sandroos With Sikanjabeen) in Cases Of Obesity (Siman Mufrit)

A Clinical Study to evaluate the efficacy and safety of Unani formulation (Sandroos and Sikanjabin) in the management of Siman Mufrit (Obesity) (IUMT-5.13.87)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091320
Enrollment
38
Registered
2025-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

Intervention1: Unani Formulation Sandroos and Sikanjabin: 1. Sandroos- DosageForm:Safuf (Powder) Dose:2.5 gm once daily Route of administration: Oral Duration of protocol therapy:06 weeks 2. Sikanja

Sponsors

State Takmeel ut Tib College And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinically diagnosed Siman Mufrit (obesity) of either sex Patients belonging to 18-60 years of age Patients having BMI between 25-35kg m2 Patient able to participate in the study and ready to follow the instructions and sign the consent form.

Exclusion criteria

Exclusion criteria: Patient below the age of 18 and above the age of 60. Pregnancy and lactating mother & women using OCP drug. Patients with systemic and other metabolic diseases. Patients having BMI more than 35kg m2. Patients who refuse to give the written informed consent for the study

Design outcomes

Primary

MeasureTime frame
Reduction in body weight Reduction in BMI Improvement in Total Sign and Symptoms ScoreTimepoint: Baseline , 2nd, 4th and 6th week

Secondary

MeasureTime frame
Improvement In the Quality of LifeTimepoint: Baseline ,2nd ,4th and 6th week

Countries

India

Contacts

Public ContactDr Mohd Zubair

State Takmeel ut Tib College And Hospital

aq.ayaz5775@gmail.com9415757169

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026